首页 > 最新文献

Perinatologia y Reproduccion Humana最新文献

英文 中文
Intervención del Instituto Nacional de Perinatología en la reducción de la mortalidad materna 国家围产期研究所对降低孕产妇死亡率的干预
Pub Date : 2017-06-01 DOI: 10.1016/j.rprh.2017.11.003
M. Cortés Bonilla
{"title":"Intervención del Instituto Nacional de Perinatología en la reducción de la mortalidad materna","authors":"M. Cortés Bonilla","doi":"10.1016/j.rprh.2017.11.003","DOIUrl":"10.1016/j.rprh.2017.11.003","url":null,"abstract":"","PeriodicalId":32275,"journal":{"name":"Perinatologia y Reproduccion Humana","volume":"31 2","pages":"Pages 53-54"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rprh.2017.11.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46787580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manifestación clínica de la composición corporal en pacientes con síndrome de ovario poliquístico 多囊卵巢综合征患者身体成分的临床表现
Pub Date : 2017-06-01 DOI: 10.1016/j.rprh.2017.10.017
S.P. Arevalo Monter , D.I. Hernández Hernández , A.M. Szustkiewicz , A. Zárate , M. Hernández Valencia

Polycystic ovary syndrome it is an endocrine-metabolic dysfunction and it is explained as a female functional hyperandrogenism. Associated to this, several systemic alterations are triggered, with one of these very important dysfunctions being the accumulation of visceral fat tissue. It has been demonstrated that the androgens and the increase of the free fatty acids, as observed in central type obesity, inhibit the hepatic action of insulin that results in compensatory hyperinsulinism secondary to insulin resistance. For this reason, patients with polycystic ovary syndrome present with diverse clinical, hormonal and metabolic characteristics, depending on their body fat and its distribution pattern. The classification into sub-groups can help to identify the systemic dysfunctions that each patient may have. One of these parameters is the phenotype associated with the body composition, which can be measured using the electrical impedance of the body fluids that helps to determine the distribution of the different components of the human body. For this reason, the study of the body composition should be now considered as part of the follow-up of patients with polycystic ovary syndrome, in order to determine the response to the treatments used in the correction of this systemic dysfunction.

多囊卵巢综合征是一种内分泌代谢功能障碍,被解释为女性功能性高雄激素症。与此相关,一些系统性改变被触发,其中一个非常重要的功能障碍是内脏脂肪组织的积累。已经证明,雄激素和游离脂肪酸的增加,正如在中心型肥胖中观察到的那样,抑制胰岛素的肝脏作用,导致继发于胰岛素抵抗的代偿性高胰岛素血症。因此,多囊卵巢综合征患者的临床、激素和代谢特征不同,这取决于他们的体脂及其分布模式。亚组分类可以帮助识别每个病人可能有的全身性功能障碍。其中一个参数是与身体成分相关的表型,可以使用体液的电阻抗来测量,这有助于确定人体不同成分的分布。因此,身体组成的研究现在应该被视为多囊卵巢综合征患者随访的一部分,以确定用于纠正这种全身功能障碍的治疗的反应。
{"title":"Manifestación clínica de la composición corporal en pacientes con síndrome de ovario poliquístico","authors":"S.P. Arevalo Monter ,&nbsp;D.I. Hernández Hernández ,&nbsp;A.M. Szustkiewicz ,&nbsp;A. Zárate ,&nbsp;M. Hernández Valencia","doi":"10.1016/j.rprh.2017.10.017","DOIUrl":"10.1016/j.rprh.2017.10.017","url":null,"abstract":"<div><p>Polycystic ovary syndrome it is an endocrine-metabolic dysfunction and it is explained as a female functional hyperandrogenism. Associated to this, several systemic alterations are triggered, with one of these very important dysfunctions being the accumulation of visceral fat tissue. It has been demonstrated that the androgens and the increase of the free fatty acids, as observed in central type obesity, inhibit the hepatic action of insulin that results in compensatory hyperinsulinism secondary to insulin resistance. For this reason, patients with polycystic ovary syndrome present with diverse clinical, hormonal and metabolic characteristics, depending on their body fat and its distribution pattern. The classification into sub-groups can help to identify the systemic dysfunctions that each patient may have. One of these parameters is the phenotype associated with the body composition, which can be measured using the electrical impedance of the body fluids that helps to determine the distribution of the different components of the human body. For this reason, the study of the body composition should be now considered as part of the follow-up of patients with polycystic ovary syndrome, in order to determine the response to the treatments used in the correction of this systemic dysfunction.</p></div>","PeriodicalId":32275,"journal":{"name":"Perinatologia y Reproduccion Humana","volume":"31 2","pages":"Pages 91-95"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rprh.2017.10.017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41287463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relación entre sobrepeso y obesidad materna con cardiopatías congénitas. Estudio retrospectivo caso-control en el área norte de Buenos Aires 母亲超重和肥胖与先天性心脏病的关系。布宜诺斯艾利斯北部地区回顾性病例对照研究
Pub Date : 2017-06-01 DOI: 10.1016/j.rprh.2017.10.007
S.M. Benítez , A.C.J. Barreto Paternina , E.A. Duro

Background

There are discrepancies around maternal pre-conception overweight and obesity and structural congenital heart disease (CHD). The worldwide prevalence of overweight and obesity has increased in women of reproductive age and this could have an impact on the health care of newborn babies.

Objectives

To estimate the risk for CHD associated with pre-conception maternal overweight and obesity in the study area.

Material and methods

A quantitative, analytical, and observational retrospective case-control and anonymised study was conducted on newborns babies with a CHD entered in the National Registry of Congenital Malformations (RENAC). They were compared against others without any malformations, in a proportion of 1:1 between 2011 and 2014.

Results

A total of 22 mother-infants pairs were included in the RENAC. According to the pre-conception BMI, the prevalence of overweight was 4/22, obesity 6/22, and normal weight 12/22. The distribution of other factors present between cases and controls was similar, with no significant differences. The distribution of CHD was similar in those with normal weight (12/22) and overweight and obesity (10/22), with no statistically significant differences. Compared with normal-weight women, the relative risk of CHD associated with maternal overweight and obesity was 1 (95% CI; 0.55-1.81) with an odds ratio of 1 (95% CI; 0.30-3.27). Septal defects were the most frequent CHD (Q21).

Conclusions

No significant relationship was found between pre-conception maternal overweight-obesity and CHD in our newborns.

背景孕妇孕前超重和肥胖与结构性先天性心脏病(CHD)之间存在差异。全世界育龄妇女超重和肥胖的流行率有所上升,这可能对新生儿的保健产生影响。目的评估研究地区孕前孕妇超重和肥胖与冠心病的相关风险。材料与方法对在国家先天性畸形登记处(RENAC)登记的CHD新生儿进行了一项定量、分析和观察性回顾性病例对照和匿名研究。2011年至2014年间,他们与其他没有任何畸形的人进行了1:1的比较。结果RENAC共纳入22对母婴。根据孕前BMI,超重患病率为4/22,肥胖患病率为6/22,正常体重患病率为12/22。其他因素在病例和对照组之间的分布相似,无显著差异。正常体重组(12/22)与超重肥胖组(10/22)冠心病分布相似,差异无统计学意义。与正常体重的妇女相比,与母亲超重和肥胖相关的冠心病的相对风险为1 (95% CI;0.55-1.81),优势比为1 (95% CI;0.30 - -3.27)。室间隔缺损是最常见的冠心病(Q21)。结论孕前孕妇超重肥胖与新生儿冠心病无明显关系。
{"title":"Relación entre sobrepeso y obesidad materna con cardiopatías congénitas. Estudio retrospectivo caso-control en el área norte de Buenos Aires","authors":"S.M. Benítez ,&nbsp;A.C.J. Barreto Paternina ,&nbsp;E.A. Duro","doi":"10.1016/j.rprh.2017.10.007","DOIUrl":"10.1016/j.rprh.2017.10.007","url":null,"abstract":"<div><h3>Background</h3><p>There are discrepancies around maternal pre-conception overweight and obesity and structural congenital heart disease (CHD). The worldwide prevalence of overweight and obesity has increased in women of reproductive age and this could have an impact on the health care of newborn babies.</p></div><div><h3>Objectives</h3><p>To estimate the risk for CHD associated with pre-conception maternal overweight and obesity in the study area.</p></div><div><h3>Material and methods</h3><p>A quantitative, analytical, and observational retrospective case-control and anonymised study was conducted on newborns babies with a CHD entered in the National Registry of Congenital Malformations (RENAC). They were compared against others without any malformations, in a proportion of 1:1 between 2011 and 2014.</p></div><div><h3>Results</h3><p>A total of 22 mother-infants pairs were included in the RENAC. According to the pre-conception BMI, the prevalence of overweight was 4/22, obesity 6/22, and normal weight 12/22. The distribution of other factors present between cases and controls was similar, with no significant differences. The distribution of CHD was similar in those with normal weight (12/22) and overweight and obesity (10/22), with no statistically significant differences. Compared with normal-weight women, the relative risk of CHD associated with maternal overweight and obesity was 1 (95% CI; 0.55-1.81) with an odds ratio of 1 (95% CI; 0.30-3.27). Septal defects were the most frequent CHD (Q21).</p></div><div><h3>Conclusions</h3><p>No significant relationship was found between pre-conception maternal overweight-obesity and CHD in our newborns.</p></div>","PeriodicalId":32275,"journal":{"name":"Perinatologia y Reproduccion Humana","volume":"31 2","pages":"Pages 73-77"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rprh.2017.10.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49517753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adiponectina plasmática en mujeres obesas y no obesas con síndrome de ovarios poliquísticos
Pub Date : 2017-06-01 DOI: 10.1016/j.rprh.2017.10.018
J. Mejia-Montilla , M. Álvarez-Mon , E. Reyna-Villasmil , D. Torres-Cepeda , N. Reyna-Villasmil , A. Fernández-Ramírez , A. Bravo-Henríquez

Objective

To determine plasma adiponectin concentrations in obese and non-obese women with polycystic ovary syndrome (PCOS).

Materials and methods

A Case control study was conducted on women with a diagnosis of PCOS and age-matched healthy controls, with regular menstruation and normal ultrasound ovaries, were selected. Participants were divided into four groups (Group A: PCOS and obese; Group B: PCOS and non-obese; Group C: obese controls, and Group D: non-obese controls) according to body mass index (obese > 30 kg/m2 and non-obese < 25 kg/m2). Concentrations of sexual hormones, sex hormone-binding globulin, serum glucose, insulin, and adiponectin, were measured.

Results

Obese and non-obese women with PCOS had higher luteinising hormone, follicle stimulating hormone, androstenedione, testosterone, and insulin levels compared to women in the obese and non-obese control group, respectively (P < .0001). Women with PCOS had a significantly lower concentration of adiponectin (Group A: 8.3 ± 1.6 ng/mL and Group B: 10.1 ± 1.4 ng/mL), compared with controls (Group C: 12.1 ± 2.8 ng/mL and Group D: 14.7 ± 2.6 ng/dL; P < .0001). It was observed that adiponectin concentrations had a positive and significant association with fasting blood glucose and insulin in PCOS women (P < .05).

Conclusion

There are significant differences in plasma adiponectin concentrations between obese and non-obese women with polycystic ovary syndrome and normal controls.

目的测定肥胖和非肥胖多囊卵巢综合征(PCOS)患者血浆脂联素水平。材料与方法选择经诊断为多囊卵巢综合征(PCOS)的女性和年龄匹配、月经规律、超声卵巢正常的健康对照进行病例对照研究。参与者分为四组(A组:多囊卵巢综合征和肥胖;B组:多囊卵巢综合征和非肥胖;C组:肥胖对照组,D组:非肥胖对照组)根据体重指数(肥胖>30公斤/平方米,非肥胖<25 kg / m2)。测定性激素、性激素结合球蛋白、血清葡萄糖、胰岛素和脂联素的浓度。结果肥胖和非肥胖PCOS患者的黄体生成素、卵泡刺激素、雄烯二酮、睾酮和胰岛素水平分别高于肥胖对照组和非肥胖对照组(P <。)。PCOS女性脂联素浓度(a组:8.3±1.6 ng/mL, B组:10.1±1.4 ng/mL)明显低于对照组(C组:12.1±2.8 ng/mL, D组:14.7±2.6 ng/dL;P & lt;。)。观察到脂联素浓度与PCOS女性空腹血糖和胰岛素呈显著正相关(P <. 05)。结论肥胖与非肥胖多囊卵巢综合征患者血浆脂联素浓度与正常对照有显著差异。
{"title":"Adiponectina plasmática en mujeres obesas y no obesas con síndrome de ovarios poliquísticos","authors":"J. Mejia-Montilla ,&nbsp;M. Álvarez-Mon ,&nbsp;E. Reyna-Villasmil ,&nbsp;D. Torres-Cepeda ,&nbsp;N. Reyna-Villasmil ,&nbsp;A. Fernández-Ramírez ,&nbsp;A. Bravo-Henríquez","doi":"10.1016/j.rprh.2017.10.018","DOIUrl":"10.1016/j.rprh.2017.10.018","url":null,"abstract":"<div><h3>Objective</h3><p>To determine plasma adiponectin concentrations in obese and non-obese women with polycystic ovary syndrome (PCOS).</p></div><div><h3>Materials and methods</h3><p>A Case control study was conducted on women with a diagnosis of PCOS and age-matched healthy controls, with regular menstruation and normal ultrasound ovaries, were selected. Participants were divided into four groups (Group A: PCOS and obese; Group B: PCOS and non-obese; Group C: obese controls, and Group D: non-obese controls) according to body mass index (obese &gt;<!--> <!-->30<!--> <!-->kg/m<sup>2</sup> and non-obese &lt;<!--> <!-->25<!--> <!-->kg/m<sup>2</sup>). Concentrations of sexual hormones, sex hormone-binding globulin, serum glucose, insulin, and adiponectin, were measured.</p></div><div><h3>Results</h3><p>Obese and non-obese women with PCOS had higher luteinising hormone, follicle stimulating hormone, androstenedione, testosterone, and insulin levels compared to women in the obese and non-obese control group, respectively (<em>P</em> <!-->&lt;<!--> <!-->.0001). Women with PCOS had a significantly lower concentration of adiponectin (Group A: 8.3<!--> <!-->±<!--> <!-->1.6<!--> <!-->ng/mL and Group B: 10.1<!--> <!-->±<!--> <!-->1.4<!--> <!-->ng/mL), compared with controls (Group C: 12.1<!--> <!-->±<!--> <!-->2.8<!--> <!-->ng/mL and Group D: 14.7<!--> <!-->±<!--> <!-->2.6<!--> <!-->ng/dL; <em>P</em> <!-->&lt;<!--> <!-->.0001). It was observed that adiponectin concentrations had a positive and significant association with fasting blood glucose and insulin in PCOS women (<em>P</em> <!-->&lt;<!--> <!-->.05).</p></div><div><h3>Conclusion</h3><p>There are significant differences in plasma adiponectin concentrations between obese and non-obese women with polycystic ovary syndrome and normal controls.</p></div>","PeriodicalId":32275,"journal":{"name":"Perinatologia y Reproduccion Humana","volume":"31 2","pages":"Pages 62-67"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rprh.2017.10.018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41672026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pérdida sanguínea y uso de hemoderivados en casos de cesárea e histerectomía por acretismo placentario 剖腹产和胎盘吸积子宫切除术的失血和血液衍生物的使用
Pub Date : 2017-06-01 DOI: 10.1016/j.rprh.2017.10.010
J.F. Solórzano Vázquez , G. Ruvalcaba Ortiz , S. Hernández Higareda , C.N. Morales de Avila

Background

Placenta accreta is a pathology that is associated with an elevated risk of haemorrhage, thus endangering the life of the obstetric patients. It is a public health problem, due to maternal morbidity and mortality.

There are multiple lines of management; however caesarean hysterectomy is the method of choice to resolve a pregnancy with placental accreta.

It is a procedure of high risk, even as a programmed surgery. The surgical and medical teams are challenged by the risk of massive haemorrhage and need to have rapid access to blood products to maintain haemostasis and haemodynamic balance.

Objective

To quantify blood loss, as well as the amount of blood derivatives used in patients in whom a caesarean hysterectomy was required due to placenta accreta.

Material and methods

A cross-sectional study was conducted that included patients that required a caesarean hysterectomy due to placenta accreta within a period of 4 years.

Results

A total of 106 cases of placenta accreta were studied, with 64.15% of the patients having a history of abortion and curettage, and 76.41% had at least 1 caesarean section. The mean blood loss was 2523.87 millilitres, with over 23.5% having a massive haemorrhage (> 3000 cc). Red blood cells transfusions were necessary in 68.98% of the cases. Fresh frozen plasma was given to 29.24% of the patients, and platelet concentrates were used in 6.6% of the cases.

Conclusions

Timely detection of placenta accreta in patients, an adequate surgical technique and experience, as well as the use of blood derivatives, are the cornerstones in the management of this disease.

背景:胎盘增生是一种与出血风险升高相关的病理,从而危及产科患者的生命。由于产妇发病率和死亡率,这是一个公共卫生问题。有多条管理线路;然而,剖宫产是解决妊娠伴有胎盘增生的首选方法。这是一个高风险的过程,即使作为一个程序手术。外科和医疗小组面临大出血风险的挑战,需要迅速获得血液制品,以维持止血和血流动力学平衡。目的量化因胎盘增生而行剖宫产术患者的失血量及血液衍生物用量。材料与方法对4年内因胎盘增生需要剖宫产的患者进行了一项横断面研究。结果本院共收治胎盘增生106例,64.15%的患者有流产及刮宫史,76.41%的患者至少有1次剖宫产史。平均失血量为2523.87毫升,超过23.5%发生大出血(>3000 cc)。68.98%的病例需要输注红细胞。29.24%的患者使用新鲜冷冻血浆,6.6%的患者使用血小板浓缩物。结论及时发现患者的胎盘增生,充分的手术技术和经验,以及血液衍生物的使用是治疗此病的基石。
{"title":"Pérdida sanguínea y uso de hemoderivados en casos de cesárea e histerectomía por acretismo placentario","authors":"J.F. Solórzano Vázquez ,&nbsp;G. Ruvalcaba Ortiz ,&nbsp;S. Hernández Higareda ,&nbsp;C.N. Morales de Avila","doi":"10.1016/j.rprh.2017.10.010","DOIUrl":"10.1016/j.rprh.2017.10.010","url":null,"abstract":"<div><h3>Background</h3><p>Placenta accreta is a pathology that is associated with an elevated risk of haemorrhage, thus endangering the life of the obstetric patients. It is a public health problem, due to maternal morbidity and mortality.</p><p>There are multiple lines of management; however caesarean hysterectomy is the method of choice to resolve a pregnancy with placental accreta.</p><p>It is a procedure of high risk, even as a programmed surgery. The surgical and medical teams are challenged by the risk of massive haemorrhage and need to have rapid access to blood products to maintain haemostasis and haemodynamic balance.</p></div><div><h3>Objective</h3><p>To quantify blood loss, as well as the amount of blood derivatives used in patients in whom a caesarean hysterectomy was required due to placenta accreta.</p></div><div><h3>Material and methods</h3><p>A cross-sectional study was conducted that included patients that required a caesarean hysterectomy due to placenta accreta within a period of 4 years.</p></div><div><h3>Results</h3><p>A total of 106 cases of placenta accreta were studied, with 64.15% of the patients having a history of abortion and curettage, and 76.41% had at least 1 caesarean section. The mean blood loss was 2523.87 millilitres, with over 23.5% having a massive haemorrhage (&gt; 3000 cc). Red blood cells transfusions were necessary in 68.98% of the cases. Fresh frozen plasma was given to 29.24% of the patients, and platelet concentrates were used in 6.6% of the cases.</p></div><div><h3>Conclusions</h3><p>Timely detection of placenta accreta in patients, an adequate surgical technique and experience, as well as the use of blood derivatives, are the cornerstones in the management of this disease.</p></div>","PeriodicalId":32275,"journal":{"name":"Perinatologia y Reproduccion Humana","volume":"31 2","pages":"Pages 55-61"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rprh.2017.10.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47078523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Proyecto de atención preventiva de mujeres con alto riesgo reproductivo 为生殖风险高的妇女提供预防性保健项目
Pub Date : 2017-06-01 DOI: 10.1016/j.rprh.2017.11.001
A. Cardona Pérez , M. Cortés Bonilla , N. Velázquez Ramírez , M.J. Díaz Jiménez , Y. Varela Chávez , R. Figueroa Damián

The reduction in maternal mortality has been seen as a global priority over the past twenty years or so. Many countries, including Mexico, have been committed to developing strategies to meet the aims of the fourth Millennium Development Goal of the Nations United. The maternal mortality due to obstetric causes has shown a downward trend in Mexico in the last twenty years. However, an upward trend is observed when analysing maternal mortality due to indirect causes.

With the objective of contributing to the reduction of maternal mortality due to indirect causes, the Instituto Nacional de Perinatología has proposed the project of ‘High-Risk Reproductive Modules’. This consists in the application of a set of pre-conception care interventions, to be applied in Medical Units where women with serious illnesses receive medical attention, and who, on being adequately controlled and within reproductive age, become pregnant, with the pregnancy being a factor of poor prognosis for the patient.

The project is a strategy in the medical care of women within reproductive age with chronic or systemic diseases, which includes two fundamental objectives: 1) improvement of health care services, 2) improvement of the health of the population. The implementation of this project has the objective of contributing to the reduction of maternal mortality due to an indirect cause, and by using this strategy to reduce the existing gaps in health conditions among the population of our country.

在过去20年左右的时间里,降低孕产妇死亡率一直被视为全球优先事项。包括墨西哥在内的许多国家一直致力于制定战略,以实现联合国第四个千年发展目标的各项目标。在过去二十年中,墨西哥因产科原因造成的产妇死亡率呈下降趋势。然而,在分析间接原因造成的产妇死亡率时,发现了上升趋势。为了帮助减少间接原因造成的产妇死亡率,Perinatología国家研究所提出了“高风险生殖模式”项目。这包括实施一套孕前护理干预措施,这些措施将在医疗单位实施,在这些医疗单位,患有严重疾病的妇女在得到适当控制和育龄期间怀孕,怀孕是患者预后不良的一个因素。该项目是对患有慢性或全身性疾病的育龄妇女的医疗保健战略,包括两个基本目标:1)改善保健服务;2)改善人口健康。实施这一项目的目的是促进减少因间接原因造成的产妇死亡率,并利用这一战略缩小我国人口在保健条件方面的现有差距。
{"title":"Proyecto de atención preventiva de mujeres con alto riesgo reproductivo","authors":"A. Cardona Pérez ,&nbsp;M. Cortés Bonilla ,&nbsp;N. Velázquez Ramírez ,&nbsp;M.J. Díaz Jiménez ,&nbsp;Y. Varela Chávez ,&nbsp;R. Figueroa Damián","doi":"10.1016/j.rprh.2017.11.001","DOIUrl":"10.1016/j.rprh.2017.11.001","url":null,"abstract":"<div><p>The reduction in maternal mortality has been seen as a global priority over the past twenty years or so. Many countries, including Mexico, have been committed to developing strategies to meet the aims of the fourth Millennium Development Goal of the Nations United. The maternal mortality due to obstetric causes has shown a downward trend in Mexico in the last twenty years. However, an upward trend is observed when analysing maternal mortality due to indirect causes.</p><p>With the objective of contributing to the reduction of maternal mortality due to indirect causes, the <em>Instituto Nacional de Perinatología</em> has proposed the project of ‘High-Risk Reproductive Modules’. This consists in the application of a set of pre-conception care interventions, to be applied in Medical Units where women with serious illnesses receive medical attention, and who, on being adequately controlled and within reproductive age, become pregnant, with the pregnancy being a factor of poor prognosis for the patient.</p><p>The project is a strategy in the medical care of women within reproductive age with chronic or systemic diseases, which includes two fundamental objectives: 1) improvement of health care services, 2) improvement of the health of the population. The implementation of this project has the objective of contributing to the reduction of maternal mortality due to an indirect cause, and by using this strategy to reduce the existing gaps in health conditions among the population of our country.</p></div>","PeriodicalId":32275,"journal":{"name":"Perinatologia y Reproduccion Humana","volume":"31 2","pages":"Pages 96-104"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rprh.2017.11.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43110309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Índice de perfusión periférica en la UCI neonatal: una respuesta a la monitorización no invasiva del recién nacido crítico 新生儿重症监护室外周灌注指数:对关键新生儿无创监测的一种反应
Pub Date : 2017-06-01 DOI: 10.1016/j.rprh.2017.10.015
I. De La Peña Sanabria , M. Ochoa Martelo , H. Baquero Latorre , J. Acosta-Reyes

The need to address and monitor patients minimally invasively, but more accurately, and thereby reducing the number of complications, has led to developing the concept of perfusion index over the years. The perfusion index reflects the peripheral vasomotor tone, due to the relationship of pulsatile and non-pulsatile waves through a pulse oximeter. The newborn, especially pre-term, have a number of features that make them more vulnerable to certain clinical situations, as such that the physiological response differs from that of other population groups. Hence, the main interest in this new tool, which would help in the understanding of the complex neonatal cardiovascular physiology and thus better interpret their response in order to make timely interventions. The following article presents the history and physiological basis that helped develop the perfusion index, as well as describing the most recent studies in the neonatal population.

多年来,为了更准确、微创地对患者进行定位和监测,从而减少并发症的发生,灌注指数的概念应运而生。灌注指数反映了周围血管舒缩张力,这是由于脉搏血氧计的脉动波和非脉动波的关系。新生儿,特别是早产儿,有许多特点使他们更容易受到某些临床情况的影响,因此生理反应与其他人群不同。因此,主要的兴趣在这个新的工具,这将有助于理解复杂的新生儿心血管生理,从而更好地解释他们的反应,以便及时干预。下面的文章介绍了历史和生理基础,帮助制定灌注指数,并描述了最新的研究在新生儿群体。
{"title":"Índice de perfusión periférica en la UCI neonatal: una respuesta a la monitorización no invasiva del recién nacido crítico","authors":"I. De La Peña Sanabria ,&nbsp;M. Ochoa Martelo ,&nbsp;H. Baquero Latorre ,&nbsp;J. Acosta-Reyes","doi":"10.1016/j.rprh.2017.10.015","DOIUrl":"10.1016/j.rprh.2017.10.015","url":null,"abstract":"<div><p>The need to address and monitor patients minimally invasively, but more accurately, and thereby reducing the number of complications, has led to developing the concept of perfusion index over the years. The perfusion index reflects the peripheral vasomotor tone, due to the relationship of pulsatile and non-pulsatile waves through a pulse oximeter. The newborn, especially pre-term, have a number of features that make them more vulnerable to certain clinical situations, as such that the physiological response differs from that of other population groups. Hence, the main interest in this new tool, which would help in the understanding of the complex neonatal cardiovascular physiology and thus better interpret their response in order to make timely interventions. The following article presents the history and physiological basis that helped develop the perfusion index, as well as describing the most recent studies in the neonatal population.</p></div>","PeriodicalId":32275,"journal":{"name":"Perinatologia y Reproduccion Humana","volume":"31 2","pages":"Pages 85-90"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rprh.2017.10.015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42396313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Caracterización epidemiológica de la retinopatía del prematuro en el Hospital de la Amistad Corea-México. Período 2005 a 2014 早产儿视网膜病的流行病学特征在Corea-México友谊医院。2005年至2014年
Pub Date : 2017-03-01 DOI: 10.1016/j.rprh.2017.10.001
L.M. Cauich-Aragón, M.A. De la Fuente-Torres, E. Sánchez-Buenfil, R. Farías-Cid

Introduction

Retinophaty of prematurity (ROP) is a disease in which abnormal neovascularization develops in the retina and could be a cause of blindness.

Objective

To determine severe ROP prevalence.

Material and methods

In this retrospective, observational, descriptive, transverse study, we did a review of the clinical records of premature patients with < 34 weeks of gestation and a birth weight < 1,750 g, and neonates with a gestational age >34 weeks and birth weight > 1,750 g if they have risk factors for ROP. From 2005 to 2014, all the newborns were examined by a retinologist. ROP prevalence per year was determined, only the prevalence for severe ROP was compared because it requires treatment and has a high risk for blidness.

Results

One hundred forty-three newborns were included, 29 (20.2%) had severe ROP. When comparing for years there was a peak during 2005, with a descend in the prevalence of severe ROP in 2014, so in ten years there was a downward trend.

Conclusions

Severe ROP cumulated prevalence was 20.2%, similar to that observed in other latinoamerican countries. The high prevalence observed from 2005 to 2009, is explained because we examined patients refered from other institutions without screening programs for ROP. In 2010 we observed a descend in the prevalence, because only patient from our institution were included. From 2011 to 2014 we report none blind children with ROP.

早产儿视网膜病变(ROP)是一种视网膜新生血管发育异常的疾病,可导致失明。目的确定严重ROP的患病率。材料与方法在这项回顾性、观察性、描述性、横向研究中,我们对早产儿<妊娠34周,出生体重1750 g,胎龄34周和出生体重为1750 g的新生儿如果他们有ROP的危险因素。从2005年到2014年,所有的新生儿都接受了眼科医生的检查。确定了每年ROP的患病率,仅比较了严重ROP的患病率,因为它需要治疗并且有很高的失明风险。结果纳入143例新生儿,重度ROP 29例(20.2%)。从年份对比来看,2005年为高峰,2014年严重ROP患病率有所下降,10年呈下降趋势。结论严重ROP累计患病率为20.2%,与其他拉美国家相似。从2005年到2009年观察到的高患病率,可以解释为我们检查了从其他机构转来的没有ROP筛查项目的患者。在2010年,我们观察到患病率下降,因为只有来自我们机构的患者被纳入。从2011年到2014年,我们没有报告失明儿童患ROP。
{"title":"Caracterización epidemiológica de la retinopatía del prematuro en el Hospital de la Amistad Corea-México. Período 2005 a 2014","authors":"L.M. Cauich-Aragón,&nbsp;M.A. De la Fuente-Torres,&nbsp;E. Sánchez-Buenfil,&nbsp;R. Farías-Cid","doi":"10.1016/j.rprh.2017.10.001","DOIUrl":"10.1016/j.rprh.2017.10.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Retinophaty of prematurity (ROP) is a disease in which abnormal neovascularization develops in the retina and could be a cause of blindness.</p></div><div><h3>Objective</h3><p>To determine severe ROP prevalence.</p></div><div><h3>Material and methods</h3><p>In this retrospective, observational, descriptive, transverse study, we did a review of the clinical records of premature patients with <u>&lt;</u> 34 weeks of gestation and a birth weight <u>&lt;</u> 1,750<!--> <!-->g, and neonates with a gestational age &gt;34 weeks and birth weight &gt; 1,750<!--> <!-->g if they have risk factors for ROP. From 2005 to 2014, all the newborns were examined by a retinologist. ROP prevalence per year was determined, only the prevalence for severe ROP was compared because it requires treatment and has a high risk for blidness.</p></div><div><h3>Results</h3><p>One hundred forty-three newborns were included, 29 (20.2%) had severe ROP. When comparing for years there was a peak during 2005, with a descend in the prevalence of severe ROP in 2014, so in ten years there was a downward trend.</p></div><div><h3>Conclusions</h3><p>Severe ROP cumulated prevalence was 20.2%, similar to that observed in other latinoamerican countries. The high prevalence observed from 2005 to 2009, is explained because we examined patients refered from other institutions without screening programs for ROP. In 2010 we observed a descend in the prevalence, because only patient from our institution were included. From 2011 to 2014 we report none blind children with ROP.</p></div>","PeriodicalId":32275,"journal":{"name":"Perinatologia y Reproduccion Humana","volume":"31 1","pages":"Pages 21-27"},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rprh.2017.10.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49286552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Reemplazo renal continuo en eclampsia y síndrome de HELLP. Reporte de un caso 子痫和help综合征的持续肾脏置换。报告个案
Pub Date : 2017-03-01 DOI: 10.1016/j.rprh.2017.10.004
L.A. Ramírez Palacios

Introduction

Preeclampsia is considered a maternal multisystemic disease mediated by injury to the endothelium, which could be modified by characteristics such as: age, obesity, and cardiovascular disease, among other factors.

Case report

The case is presented of a 33 year-old pregnant woman, who during her stay at Hospital General Regional, Lic. Emilio Sánchez Piedras, developed eclampsia and HELLP syndrome during hospital admission. She also progressed to kidney injury (AKIN 3), which required treatment with slow continuous renal replacement therapy (CRRT). She also acquired a hepatic subcapsular haematoma, diagnosed by abdominal tomography.

Conclusions

The use of CRRT is a novel treatment in pregnant or post-partum patients, who develop AKI, co-existing with fluid overload in the presence of anuria and haemodynamic instability problems, which increase maternal morbidity and mortality.

先兆子痫被认为是一种由内皮细胞损伤介导的母体多系统疾病,可能受到年龄、肥胖、心血管疾病等因素的影响。病例报告:该病例为一名33岁孕妇,在Lic总区医院住院期间。Emilio Sánchez Piedras在入院期间出现子痫和HELLP综合征。她也进展为肾损伤(AKIN 3),需要缓慢持续肾替代疗法(CRRT)治疗。她还获得了肝包膜下血肿,通过腹部断层扫描诊断。结论CRRT是妊娠或产后AKI患者的一种新的治疗方法,这些患者在无尿和血流动力学不稳定的情况下同时存在体液超载,增加了孕产妇的发病率和死亡率。
{"title":"Reemplazo renal continuo en eclampsia y síndrome de HELLP. Reporte de un caso","authors":"L.A. Ramírez Palacios","doi":"10.1016/j.rprh.2017.10.004","DOIUrl":"10.1016/j.rprh.2017.10.004","url":null,"abstract":"<div><h3>Introduction</h3><p>Preeclampsia is considered a maternal multisystemic disease mediated by injury to the endothelium, which could be modified by characteristics such as: age, obesity, and cardiovascular disease, among other factors.</p></div><div><h3>Case report</h3><p>The case is presented of a 33 year-old pregnant woman, who during her stay at Hospital General Regional, Lic. Emilio Sánchez Piedras, developed eclampsia and HELLP syndrome during hospital admission. She also progressed to kidney injury (AKIN 3), which required treatment with slow continuous renal replacement therapy (CRRT). She also acquired a hepatic subcapsular haematoma, diagnosed by abdominal tomography.</p></div><div><h3>Conclusions</h3><p>The use of CRRT is a novel treatment in pregnant or post-partum patients, who develop AKI, co-existing with fluid overload in the presence of anuria and haemodynamic instability problems, which increase maternal morbidity and mortality.</p></div>","PeriodicalId":32275,"journal":{"name":"Perinatologia y Reproduccion Humana","volume":"31 1","pages":"Pages 48-52"},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rprh.2017.10.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47687432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resultados perinatales en mujeres mexicanas con lupus eritematoso sistémico 墨西哥系统性红斑狼疮妇女的围产期结果
Pub Date : 2017-03-01 DOI: 10.1016/j.rprh.2017.10.009
B. Farfan-Labonne , I. Luis-Vásquez , A. Ávila-Carrasco , J. Ramírez-Peredo , M. Rodríguez-Bosch , J. Beltrán-Montoya , E. Reyes-Muñoz

Objective

To determine the perinatal outcomes among Mexican women with singleton pregnancy and systemic lupus erythematosus.

Material and methods

Historical cohort study on women diagnosed with systemic lupus erythematosus, singleton pregnancy, prenatal care, and resolution between 2010 and 2015. The incidence of the following perinatal outcomes was calculated: pre-term birth, stillbirth, oligohydramnios, miscarriage, premature rupture of membranes, gestational hypertension, preeclampsia, intrauterine growth restriction, and congenital defects.

Results

A total of 122 women were included. The characteristics of the study population at admission and resolution were: maternal age 26.2 ± 6 years, maternal weight 63.4 ± 11.1 kg, body mass index 26 ± 3.9 kg/ m2, number of gestations 1.9 ± 1.2, gestational weeks at admission 16.6 ± 6.5, gestational weeks at resolution 36.1 ± 3.4, neonatal weight 2,417-770 g. The incidence of adverse perinatal outcomes was: pre-term birth 41.8%, death 1.6%, oligohydramnios 6.6%, miscarriage 5.7%, premature rupture of membranes 9.8%, gestational hypertension 5.7%, preeclampsia 24.6%, early onset preeclampsia 15.6%, anaemia 23%, intrauterine growth restriction 14.7%, congenital defects 2.4%, and caesarean 78.2%.

Conclusions

Mexican women with systemic lupus erythematosus have high incidence of pre-term birth, preeclampsia, anaemia, early onset preeclampsia, intrauterine growth restriction, oligohydramnios and caesarean. Furthermore, the incidence of live births is among the highest reported in the literature.

目的探讨墨西哥单胎妊娠合并系统性红斑狼疮的围产儿结局。资料与方法2010 - 2015年间诊断为系统性红斑狼疮、单胎妊娠、产前护理和治疗的女性的历史队列研究。计算以下围产期结局的发生率:早产、死产、羊水过少、流产、胎膜早破、妊娠期高血压、先兆子痫、宫内生长受限和先天性缺陷。结果共纳入122名妇女。研究人群入院和出院时的特征为:产妇年龄26.2±6岁,体重63.4±11.1 kg,体重指数26±3.9 kg/ m2,妊娠数1.9±1.2,入院时妊娠周数16.6±6.5,入院时妊娠周数36.1±3.4,新生儿体重2,417-770 g。围产期不良结局发生率为:早产41.8%,死亡1.6%,羊水过少6.6%,流产5.7%,胎膜早破9.8%,妊娠期高血压5.7%,子痫前期24.6%,早发型子痫前期15.6%,贫血23%,宫内生长受限14.7%,先天性缺陷2.4%,剖腹产78.2%。结论墨西哥系统性红斑狼疮妇女早产、子痫前期、贫血、早发性子痫前期、宫内生长受限、羊水过少、剖宫产发生率高。此外,活产率是文献报道中最高的。
{"title":"Resultados perinatales en mujeres mexicanas con lupus eritematoso sistémico","authors":"B. Farfan-Labonne ,&nbsp;I. Luis-Vásquez ,&nbsp;A. Ávila-Carrasco ,&nbsp;J. Ramírez-Peredo ,&nbsp;M. Rodríguez-Bosch ,&nbsp;J. Beltrán-Montoya ,&nbsp;E. Reyes-Muñoz","doi":"10.1016/j.rprh.2017.10.009","DOIUrl":"10.1016/j.rprh.2017.10.009","url":null,"abstract":"<div><h3>Objective</h3><p>To determine the perinatal outcomes among Mexican women with singleton pregnancy and systemic lupus erythematosus.</p></div><div><h3>Material and methods</h3><p>Historical cohort study on women diagnosed with systemic lupus erythematosus, singleton pregnancy, prenatal care, and resolution between 2010 and 2015. The incidence of the following perinatal outcomes was calculated: pre-term birth, stillbirth, oligohydramnios, miscarriage, premature rupture of membranes, gestational hypertension, preeclampsia, intrauterine growth restriction, and congenital defects.</p></div><div><h3>Results</h3><p>A total of 122 women were included. The characteristics of the study population at admission and resolution were: maternal age 26.2<!--> <!-->±<!--> <!-->6 years, maternal weight 63.4<!--> <!-->±<!--> <!-->11.1<!--> <!-->kg, body mass index 26<!--> <!-->±<!--> <!-->3.9<!--> <!-->kg/ m<sup>2</sup>, number of gestations 1.9<!--> <!-->±<!--> <!-->1.2, gestational weeks at admission 16.6<!--> <!-->±<!--> <!-->6.5, gestational weeks at resolution 36.1<!--> <!-->±<!--> <!-->3.4, neonatal weight 2,417-770<!--> <!-->g. The incidence of adverse perinatal outcomes was: pre-term birth 41.8%, death 1.6%, oligohydramnios 6.6%, miscarriage 5.7%, premature rupture of membranes 9.8%, gestational hypertension 5.7%, preeclampsia 24.6%, early onset preeclampsia 15.6%, anaemia 23%, intrauterine growth restriction 14.7%, congenital defects 2.4%, and caesarean 78.2%.</p></div><div><h3>Conclusions</h3><p>Mexican women with systemic lupus erythematosus have high incidence of pre-term birth, preeclampsia, anaemia, early onset preeclampsia, intrauterine growth restriction, oligohydramnios and caesarean. Furthermore, the incidence of live births is among the highest reported in the literature.</p></div>","PeriodicalId":32275,"journal":{"name":"Perinatologia y Reproduccion Humana","volume":"31 1","pages":"Pages 3-9"},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rprh.2017.10.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46902627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Perinatologia y Reproduccion Humana
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1